1. Home
  2. FDP vs PHVS Comparison

FDP vs PHVS Comparison

Compare FDP & PHVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fresh Del Monte Produce Inc.

FDP

Fresh Del Monte Produce Inc.

HOLD

Current Price

$32.63

Market Cap

1.7B

ML Signal

HOLD

Logo Pharvaris N.V.

PHVS

Pharvaris N.V.

HOLD

Current Price

$28.59

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FDP
PHVS
Founded
1886
2015
Country
Cayman Islands
Switzerland
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.8B
IPO Year
1999
2020

Fundamental Metrics

Financial Performance
Metric
FDP
PHVS
Price
$32.63
$28.59
Analyst Decision
Buy
Analyst Count
0
11
Target Price
N/A
$41.82
AVG Volume (30 Days)
291.9K
373.3K
Earning Date
05-05-2026
05-12-2026
Dividend Yield
2.89%
N/A
EPS Growth
N/A
N/A
EPS
0.21
N/A
Revenue
$4,322,300,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.14
N/A
P/E Ratio
$156.14
N/A
Revenue Growth
0.98
N/A
52 Week Low
$31.85
$15.51
52 Week High
$43.58
$33.33

Technical Indicators

Market Signals
Indicator
FDP
PHVS
Relative Strength Index (RSI) 17.23 46.46
Support Level $32.40 $24.73
Resistance Level $36.48 $28.72
Average True Range (ATR) 1.47 1.65
MACD -0.67 -0.21
Stochastic Oscillator 1.67 7.20

Price Performance

Historical Comparison
FDP
PHVS

About FDP Fresh Del Monte Produce Inc.

Fresh Del Monte Produce Inc is an integrated producer, marketer & distributor of fresh-cut fruit & vegetables. It operates in three segments, Fresh and value-added products segment, which includes pineapples, fresh-cut fruit, fresh-cut vegetables, melons, vegetables, non-tropical fruit, other fruit and vegetables, avocados, and prepared foods, Banana segment & Other products and services segment, including the third-party freight & logistic services business & the Jordanian poultry and meats business. The majority is from the Fresh and value-added products segment. Geographically, it operates in North America, Europe, Asia, the Middle East, and Other, out of which the highest is from North America.

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

Share on Social Networks: